🔴 LIVE: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

Aspen Aerogels stock price target lifted on EV market resilience

EditorNatashya Angelica
Published 08/09/2024, 08:42 AM
ASPN
-

On Friday, Canaccord Genuity maintained a positive outlook on shares of Aspen Aerogels (NYSE:ASPN), increasing the stock's price target to $29 from $28, while keeping a Buy rating. This adjustment comes as Aspen Aerogels continues to outperform despite challenges within the electric vehicle (EV) sector.

The company has successfully overcome various obstacles, such as a slowdown in the EV market and revised EV production forecasts from General Motors (NYSE:GM). Aspen's ability to exceed expectations and uplift its financial guidance has been attributed to prudent management strategies and a shift to outsourcing production for its Energy Industrial segment several months ago. The firm also noted that Aspen's diversification efforts, including the addition of new customers, are critical as the company prepares for the future.

Aspen Aerogels is also in a strategic position to address safety concerns related to EV fires, with a recent Wall Street Journal report highlighting a significant fire incident involving an EV in South Korea. The company's solutions could become increasingly vital as the industry seeks to mitigate such risks.

Canaccord Genuity's revised price target is based on applying approximately a 13x multiple to Aspen's projected 2027 earnings per share (EPS) of $2.21, up from the previous estimate of $2.15. This valuation represents a premium compared to the average trading multiples of Aspen's peer group, justified by the company's superior growth prospects.

In other recent news, Aspen Aerogels reported a strong Q2 2024 performance, marked by a significant surge in revenue and adjusted EBITDA. The company announced quarterly revenue of $118 million and adjusted EBITDA of $29 million. Aspen Aerogels has also revised its full-year outlook, expecting to be net income positive with projected revenue of at least $390 million and adjusted EBITDA of at least $60 million for 2024.

Strategic advancements were noted in the Energy Industrial business and the Electric Vehicle (EV) market, with a focus on manufacturing expansion and partnerships, as well as involvement in carbon capture projects. The company expects to supply over 225,000 vehicles and generate over $240 million in revenue in the EV thermal barrier segment.

Despite acknowledging the need for improvement in financial performance, Aspen Aerogels is optimistic about the remainder of 2024, forecasting a 63% year-over-year increase in total revenue. The company is also actively involved in carbon capture projects and is in talks with a major German OEM for a potential contract. These are some of the recent developments that are shaping the company's trajectory.

InvestingPro Insights

Aspen Aerogels' (NYSE:ASPN) recent performance and future prospects have caught the eye of analysts, with Canaccord Genuity affirming their confidence in the company's growth trajectory. To complement this perspective, InvestingPro data highlights several key metrics that may interest investors.

The company's market capitalization stands at $1.63 billion, reflecting its substantial presence in the industry. Despite a high P/E ratio of 969.04, which indicates a premium valuation, there's an underlying optimism as revenue growth over the last twelve months has surged by a remarkable 87.96%. This growth momentum is further underscored by a significant quarterly revenue growth of 144.55% as of Q2 2024.

InvestingPro Tips suggest that Aspen Aerogels is expected to see net income and sales growth in the current year, which aligns with the positive outlook from Canaccord Genuity. Additionally, the stock has demonstrated a strong return over the last year, with a 211.47% price total return, signifying robust investor confidence. For those seeking more in-depth analysis, InvestingPro offers additional insights, including more tips that delve into Aspen Aerogels' financial health and market performance, available at https://www.investing.com/pro/ASPN.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.